Matthew Shipton's Biography

Matthew Shipton, Vice President and General Manager, Novabiosis

Over the past 16 years, Matthew Shipton has amassed deep domain expertise in cell-based products and services. Currently serving as Vice President and General Manager of human primary cell supplier Novabiosis, Mr. Shipton brings an extensive track record of meeting and surpassing targeted sales objectives, and a passion for translating customer needs into solutions that exceed customer expectations. Prior to joining Novabiosis, Mr. Shipton served as the Chief Operating Officer of Hurel Corp, leading the commercial development of Hurel’s patented technology. Previous roles include: Central and Southern U.S. Regional Sales Manager for Bioreclamation IVT (formerly CelsisIVT). Prior to CelsisIVT, Mr. Shipton served as Director of North American Business Development for Cyprotex, PLC, a UK-based contract research organization ("CRO") specializing in preclinical drug discovery services. Before Cyprotex, he was Regional Sales Manager for CellzDirect, a Durham, NC based provider of primary hepatic cell-based products and services which in 2008 was acquired by Invitrogen (now Thermo Fisher). Mr. Shipton holds Master's and Bachelor's Degrees in Chemistry from, respectively, North Carolina State University and Youngstown State University.